Influence of gender on the clinical characteristics and prognosis of patients hospitalized for heart failure;Influencia del sexo en el perfil clínico y pronóstico de la insuficiencia cardiaca tras el alta hospitalaria

Revista Espanola de Cardiologia

Volumn 60, Issue 11, 2007, Pages 1135-1143

  Redondo Bermejo, Belén ^a   Pascual Figal, Domingo A ^a,b   Hurtado Martínez, José A ^a   Peñafiel Verdú, Pablo ^a   Saura Espín, Daniel ^a   Garrido Bravo, Iris P ^a   Martínez Sánchez, Juan ^a   Valdés Chávarri, Mariano ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b NONE   (Spain)

Author keywords

Heart failure; Prognosis; Women

Indexed keywords

ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMOGLOBIN BLOOD LEVEL; HOSPITAL PATIENT; HOSPITAL READMISSION; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PROGNOSIS; SEX DIFFERENCE;

EID: 37349107243     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1157/13111785     Document Type: Article

References (36)

1. American Heart Association. Heart Disease and Stroke Statistics: 2004 Update. Dallas: American Heart Association; 2002 [citado Ene 2004]. Disponible en: http://www.americanheart.org/downloadable/heart/ 1040391091015HSStats2004Update.pdf
2. Levy D, Kenchaiah S, Larson M, Benjamin E, Kupka M, Ho K, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 2002;347:1397-402.
3. Fonarow GC. The Acute Decompensated Heart Failure National Registry (ADHERE): opportunities to improve care of patients hospitalized with acute decompensated heart failure. Rev Cardiovasc Med. 2003;4:S21-30.
4. Adams KF , Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MG, Abraham WT, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005;149:209-16.
5. Cleland JG, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC, et al. The EuroHeart Failure Survey programme: a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J. 2003;24:442-63.
6. Fonarow GC, Abraham WT, Albert NM, Gattis WA, Gheorghiade M, Greenberg B, et al. Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design. Am Heart J. 2004;148:43-51.
7. Lloyd-Jones D, Larson M, Leip E, Beiser A, D'Agostino R, Kannel W, et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation. 2003;107:448-54.
8. Rodríguez-Artalejo F, Banegas Banegas J, Guallar-Castillón P. Epidemiología de la insuficiencia cardiaca. Rev Esp Cardiol. 2004;57:163-70.
9. Petrie M, Dawson N, Murdoch D, Davie A, McMurray J. Failure of women's heart. Circulation. 1999;99:2334-41.
10. Wenger NK. Women, heart failure, and heart failure therapies. Circulation. 2002;105:1526-8.
11. Rumsfeld J, Masoudi F. Sex differences implications for heart failure care. Eur Heart J. 2004;25:101-3.
12. Heiat A, Gross CP, Krumholz HM. Representation of the elderly women, and minorities in heart failure clinical trials. Arch Intern Med. 2001;161:996-1002.
13. Varela Román A, Grigorian Shamagian L, Bandin Dieguez M, Rigueiro Veloso P, González Juanatey J. Influencia del sexo en la mortalidad a largo plazo de pacientes hospitalizados por insuficiencia cardiaca con función sistólica conservada o deprimida. Rev Esp Cardiol. 2005;58:1171-80.
14. Martínez-Selles M, García Robles J, Prieto L, Domínguez Munoa M, Frades E, Díaz-Castro O, et al. Systolic dysfunction is a predictor of long term mortality in men but not in women with heart failure. Eur Heart J. 2003;25:2046-53.
15. Hernández G, Anguita M, Ojeda S, Durán C, Rodríguez A, Ruiz M, et al. Insuficiencia cardiaca con función sistólica conservada. Diferencias pronósticas según la etiología. Rev Esp Cardiol. 2006;59:346-51.
16. Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J. 2001;22:1527-60.
17. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J. 2005;26:1115-40.
18. Melenovsky V, Borlaug BA, Rosen B, Hay I, Ferruci L, Morell CH, et al. Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: the role of atrial remodeling/dysfunction. J Am Coll Cardiol. 2007;49:198-207.
19. Siirila-Waris K, Lassus J, Melin J, Peuhkurinen K, Nieminen MS, Harjola VP. Characteristics, outcomes, and predictors of 1-year mortality in patients hospitalized for acute heart failure. Eur Heart J. 2006;27:3011-7.
20. Smilde TD, Van Veldhuisen DJ, Navis G, Voors AA, Hillege HL. Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction. Circulation. 2006;114:1572-80.
21. O'Meara E, Chong KS, Gardner RS, Jardine AG, Neilly JB, McDonagh TA. The Modification of Diet in Renal Disease (MDRD) equations provide valid estimations of glomerular filtration rates in patients with advanced heart failure. Eur J Heart Fail. 2006;8:63-7.
22. Jessup M, Piña I. Is it important to examine gender differences in the epidemiology and outcome of severe heart failure? J Thorac Cardiovasc Surg. 2004;127:1247-52.
23. Fischer M, Baessler A, Schunkert H. Renin angiotensin system and gender differences in the cardiovascular system. Cardiovasc Res. 2002;53:672-7.
24. Guerra S, Leri A, Wang X, Finato N, Di Loreto C, Beltrami C, et al. Myocyte death in the failing human heart is gender dependent. Circ Res. 1999;85:856-66.
25. Levy D, Larson M, Vasan R, Kannel W, Ho K. The progression from hypertension to congestive heart failure. JAMA. 1996;275:1557-62.
26. Lund LH, Mancini D. Heart failure in women. Med Clin North Am. 2004;88:1321-45.
27. Mendes L, Davidoff R, Cupples L, Ryan T, Jacobs A. Congestive heart failure in patients with coronary artery disease: the gender paradox. Am Heart J. 1997;134:207-12.
28. Kannel WB, Seidman JM, Fercho W, Castelli WP. Vital capacity and congestive heart failure: The Framingham Study. Circulation. 1974;49:1160-6.
29. O'Meara E, Clayton T, McEntegart MB, McMurray JJ, Lang CC, Roger SD, et al. Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Circulation. 2006;113:986-4.
30. Mozaffarian D, Nye R, Levy WC. Anemia predicts mortality in severe heart failure: the prospective randomized amlodipine survival evaluation (PRAISE). J Am Coll Cardiol. 2003;41:1933-9.
31. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol. 2002;39:1780-6.
32. Hurtado-Martínez J, Pinar-Bermúdez E, Teruel-Carrillo F, Gimeno-Blanes JR, Lacunza-Ruiz J, Valdesuso R, et al. Mortalidad a corto y largo plazo en mujeres con infarto de miocardio tratado con angioplastia primaria. Rev Esp Cardiol. 2006;59:1113-22.
33. Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation. 1993;88:107-15.
34. Daly C, Clemens F, López Sendon JL, Tavazzi L, Boersma E, Danchin N, et al. Gender differences in the management and clinical outcome outcome of stable angina. Circulation. 2006;113:467-9.
35. Wieczorowska-Tobis K, Niemir Z, Guzik P, Breborowicz A, Oreopoulos DG. Difference in estimated GFR with two different formulas in elderly individuals. Int Urol Nephrol. 2006;38:1573-84.
36. Fehrman-Ekholm I, Skeppholm L. Renal function in the elderly (>70 years old) measured by means of iohexol clearance, serum creatinine, serum urea and estimated clearance. Scand J Urol Nephrol. 2004;38:73-7.